Nelson L. Michael

Active 1995–2025

Also published as
Nelson L Michael
179
Papers
28,865
Citations
94
h-index
175
i10-index

Citations

Citations per year for Nelson L. Michael1986: 1 citations1993: 1 citations1996: 4 citations1997: 35 citations1998: 67 citations1999: 64 citations2000: 39 citations2001: 65 citations2002: 59 citations2003: 55 citations2004: 48 citations2005: 53 citations2006: 54 citations2007: 38 citations2008: 31 citations2009: 34 citations2010: 112 citations2011: 141 citations2012: 163 citations2013: 219 citations2014: 283 citations2015: 264 citations2016: 264 citations2017: 376 citations2018: 299 citations2019: 1,157 citations2020: 1,293 citations2021: 1,054 citations2022: 805 citations2023: 505 citations2024: 812 citations2025: 341 citations2026: 1 citations1987–1992: no citations, so these years are not shown1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,273 citing papers, 34.5% of this breakdownUnited Kingdom: 676 citing papers, 7.1% of this breakdownChina: 468 citing papers, 4.9% of this breakdownCanada: 407 citing papers, 4.3% of this breakdownGermany: 354 citing papers, 3.7% of this breakdownFrance: 325 citing papers, 3.4% of this breakdownSouth Africa: 321 citing papers, 3.4% of this breakdownNetherlands: 289 citing papers, 3.1% of this breakdownAustralia: 281 citing papers, 3% of this breakdownSwitzerland: 234 citing papers, 2.5% of this breakdownItaly: 228 citing papers, 2.4% of this breakdownSpain: 212 citing papers, 2.2% of this breakdown
0%34.5%Other 25.5%

Fields

  • Medicine44.9%
  • Immunology and Microbiology42.4%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Neuroscience0.5%
  • Agricultural and Biological Sciences0.5%
  • Engineering0.3%
  • Other2.2%

Topics

  • HIV Research and Treatment14.1%
  • Immune Cell Function and Interaction6.3%
  • SARS-CoV-2 and COVID-19 Research5.9%
  • HIV/AIDS Research and Interventions4.9%
  • HIV/AIDS drug development and treatment4.1%
  • T-cell and B-cell Immunology3.3%
  • Other61.4%

Coauthors

All papers

Open in search
  1. SARS-CoV-2 Variants in Patients with Immunosuppression

    Authors: , , , , , - New England Journal of Medicine 2021 cited by 474

  2. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 3,028

  3. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip W. Berman, Nicole Frahm, Stephen C. De Rosa, Michael D. Alpert, Nicole L. Yates, Xiaoying Shen, Richard A. Koup, Punnee Pitisuttithum, Jaranit Kaewkungwal, Sorachai Nitayaphan, Supachai Rerks‐Ngarm, Nelson L. Michael, Jérôme H. Kim - New England Journal of Medicine 2012 cited by 1,834

  4. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frances Priddy, Erica Lazarus, Fatima Laher, Sorachai Nitayapan, Punnee Pitisuttithum, Stephan Bart, Thomas Campbell, Robert Feldman, Gregg Lucksinger, Caroline Borremans, Katleen Callewaert, Raphaele Roten, Jerald Sadoff, Lorenz Scheppler, Mo Weijtens, Karin Feddes-de Boer, Daniëlle van Manen, Jessica Vreugdenhil, Roland Zahn, Ludo Lavreys, Steven Nijs, Jeroen Tolboom, Jenny Hendriks, Zelda Euler, Maria Grazia Pau, Hanneke Schuitemaker - The Lancet 2018 cited by 342

  5. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ousman Jobe, Vincent Dussupt, Sebastian Molnar, Ursula Tran, Chandrika B. Kannadka, Sandrine Soman, Caitlin Kuklis, Michelle Zemil, Htet Khanh, Weimin Wu, Matthew Cole, Debra K. Duso, Larry Kummer, Tricia J. Lang, Shania E. Muncil, Jeffrey R. Currier, Shelly J. Krebs, Victoria R. Polonis, Saravanan Rajan, Patrick M. McTamney, Mark T. Esser, William W. Reiley, Morgane Rolland, Natalia de Val, Michael Diamond, Gregory D. Gromowski, Gary R. Matyas, Mangala Rao, Nelson L. Michael, Kayvon Modjarrad - Cell Reports 2021 cited by 186

  6. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manoj S. Nair, Vincent Dussupt, Sharon P. Daye, Xiankun Zeng, Erica K. Barkei, Hilary Staples, Kendra J. Alfson, Ricardo Carrion, Shelly J. Krebs, Dominic Paquin‐Proulx, Nicos Karasavva, Victoria R. Polonis, Linda L. Jagodzinski, Mihret F. Amare, Sandhya Vasan, Paul T. Scott, Yaoxing Huang, David D. Ho, Natalia de Val, Michael Diamond, Mark G. Lewis, Mangala Rao, Gary R. Matyas, Gregory D. Gromowski, Sheila A. Peel, Nelson L. Michael, Diane L. Bolton, Kayvon Modjarrad - Science Translational Medicine 2022 cited by 145

  7. Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

    Authors: , , , , , , , , , , , , , - The Journal of Infectious Diseases 2012 cited by 533

  8. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 333

  9. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2015 cited by 371

  10. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 635

  11. COMPASS identifies T-cell subsets correlated with clinical outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2015 cited by 291

  12. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jessica Salzwedel, Karl Salzwedel, Timothy W. Schacker, Virginia Sheikh, Ole S. Søgaard, Serena Spudich, Kathryn E. Stephenson, Jeremy Sugarman, Jeff Taylor, Pablo Tebas, Caroline T. Tiemessen, Randall Tressler, Carol D. Weiss, Lu Zheng, Merlin L. Robb, Nelson L. Michael, John W. Mellors, Steven G. Deeks, Bruce D. Walker - The Lancet HIV 2019 cited by 206

  13. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection

    Authors: , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 cited by 264

  14. Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgia D. Tomaras - Science Translational Medicine 2014 cited by 454

  15. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gary Kobinger, Nelson L. Michael, David B. Weiner, Stephen J. Thomas, Joel N. Maslow - The Lancet Infectious Diseases 2019 cited by 322

  16. Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 84

  17. Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2014 cited by 408

  18. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Beza Gebrehana, Melissa E Greenleaf, Melinda J Hamer, Nathan K Jansen, Xiaotang Jing, Jael Kagai, Kamila Kourbanova, Michael A Koren, Monica L Martin, Kathryn McGuckin Wuertz, Jason A Regules, Aaron D Sanborn, David Wallace, Lei Zhu, Gregory D Gromowski, Courtney Corbitt, Janice M Darden, Vincent Dussupt, Emily S Golub, Jarrett A Headley, Umair M Jarral, Jocelyn King, Shelly J Krebs, Jenny Lay, Regina Lilly, Jennifer Lynch, Elizabeth J Martinez, Sandra V Mayer, Samantha McGeehon, Hyunna Lee, Steven Schech, Mekdi Tadesse, Paul V Thomas, Yahel Romem, Erifile Zografos, Bob C Lin, Sandeep R Narpala, Lingshu Wang, Nicole A Doria-Rose, Robin E Carroll, Amanda Eaton, Emily D Badraslioglu, Jason M Koontz, Ugo E Nwaeze, Peter Dawson, Alexander J Noll, Christine M Orndahl, Amy Bray, Ricardo Carrion, Jean Patterson, Viraj Kulkarni, Cory Hallam, Olga Gonzalez, Michal Gazi - The Lancet Microbe 2024 cited by 53

  19. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L. Escudero Méndez, M. Anthony Moody, Anne Marie O’Sullivan, Christopher L. Owen, Dongjun Peng, Reda Rawi, Eric Sanders‐Buell, Chen‐Hsiang Shen, Andrea R. Shiakolas, Tyler Stephens, Yaroslav Tsybovsky, Courtney Tucker, Raffaello Verardi, Keyun Wang, Jing Zhou, Tongqing Zhou, George Georgiou, S. Munir Alam, Barton F. Haynes, Morgane Rolland, Gary R. Matyas, Victoria R. Polonis, Adrian B. McDermott, Daniel C. Douek, Lawrence Shapiro, Sodsai Tovanabutra, Nelson L. Michael, John R. Mascola, Merlin L. Robb, Peter D. Kwong, Nicole A. Doria‐Rose - Immunity 2019 cited by 119

  20. SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses

    Authors: , , , , , , , , , , , , , , , , - npj Vaccines 2021 cited by 75

  21. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark G. Lewis, Galit Alter, Kayvon Modjarrad, Richard G. Jarman, Kenneth H. Eckels, Nelson L. Michael, Stephen J. Thomas, Dan H. Barouch - Science 2016 cited by 504

  22. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2016 cited by 272

  23. Initiation of ART during Early Acute HIV Infection Preserves Mucosal Th17 Function and Reverses HIV-Related Immune Activation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2014 cited by 261

  24. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter B. Gilbert, Lawrence Corey, Glenda Gray, M. Juliana McElrath - The Lancet HIV 2018 cited by 124